Skip to main content
. 2016 Dec 1;3(4):146–152. doi: 10.5152/eurjrheum.2016.15099

Table 3.

Increased gene expressions of CD4+ T lymphocytes in FMF compared to those in controls

Fold p
Activin A receptor, type I (ACVR1) 1.56 0.05
C-C chemokine receptor type 7 (CCR7) 2.15 0.21
CD40 ligand (CD40LG) 1.52 0.15
Fms-related tyrosine kinase 3 ligand (FLT3LG) 1.62 0.33
Pro-Platelet basic protein (PPBP) 1.93 0.33
CD27 1.88 0.16